Cargando…

Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson’s disease associated with enhanced autophagy

Protective effects of the telomerase protein TERT have been shown in neurons and brain. We previously demonstrated that TERT protein can accumulate in mitochondria of Alzheimer’s disease (AD) brains and protect from pathological tau in primary mouse neurons. This prompted us to employ telomerase act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Tengfei, Weir, Emma J., Johnson, Mary, Korolchuk, Viktor I., Saretzki, Gabriele C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pergamon Press 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938226/ https://www.ncbi.nlm.nih.gov/pubmed/33188884 http://dx.doi.org/10.1016/j.pneurobio.2020.101953

Ejemplares similares

Telomerase in Brain: The New Kid on the Block and Its Role in Neurodegenerative Diseases
por: Saretzki, Gabriele, et al.
Publicado: (2021)

Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
por: Mendritzki, Sonja, et al.
Publicado: (2010)

Telomerase and neurons: an unusual relationship
por: Saretzki, Gabriele
Publicado: (2022)

Implications of telomeres and telomerase in endometrial pathology
por: Hapangama, D.K., et al.
Publicado: (2017)

Role of Telomeres and Telomerase in Cancer and Aging
por: Saretzki, Gabriele
Publicado: (2023)

Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
por: Lohmann, Stephanie, et al.
Publicado: (2022)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
por: Limanaqi, Fiona, et al.
Publicado: (2019)

Telomerase and mTOR in the brain: the mitochondria connection
por: Miwa, Satomi, et al.
Publicado: (2017)

Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: What Is New?
por: Grigoletto, Jessica, et al.
Publicado: (2022)

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease
por: Cersosimo, Maria Graciela
Publicado: (2015)

Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex
por: Blumenstock, Sonja, et al.
Publicado: (2017)

Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease
por: Lamonaca, Giulia, et al.
Publicado: (2020)

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
por: Li, Yang, et al.
Publicado: (2022)

Exercise-Induced Autophagy Ameliorates Motor Symptoms Progressivity in Parkinson’s Disease Through Alpha-Synuclein Degradation: A Review
por: Goenawan, Hanna, et al.
Publicado: (2023)

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
por: Shen, Ning, et al.
Publicado: (2019)

Decreased mTOR signalling reduces mitochondrial ROS in brain via accumulation of the telomerase protein TERT within mitochondria
por: Miwa, Satomi, et al.
Publicado: (2016)

Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice
por: Ye, Minsook, et al.
Publicado: (2016)

Telomerase and Telomeres in Endometrial Cancer
por: Alnafakh, Rafah A. A., et al.
Publicado: (2019)

Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
por: Guo, Mengyuan, et al.
Publicado: (2022)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice
por: Roshanbin, Sahar, et al.
Publicado: (2021)

Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease
por: Chen, Qian-Qian, et al.
Publicado: (2018)

Telomerase Activity is Downregulated Early During Human Brain Development
por: Ishaq, Abbas, et al.
Publicado: (2016)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
por: Niu, Haichen, et al.
Publicado: (2018)

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
por: Li, Wen, et al.
Publicado: (2021)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
por: Sekiya, Hiroaki, et al.
Publicado: (2022)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
por: Gómez-Benito, Mónica, et al.
Publicado: (2020)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease
por: Martinez, Paul Anthony, et al.
Publicado: (2023)

Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype
por: Faustini, Gaia, et al.
Publicado: (2022)

Alpha-Synuclein as a Pathological Link Between Chronic Traumatic Brain Injury and Parkinson's Disease
por: Acosta, Sandra A, et al.
Publicado: (2015)

Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain
por: Roberts, Rosalind F., et al.
Publicado: (2015)

Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
por: Cai, Waijiao, et al.
Publicado: (2022)

Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s disease
por: Vacchi, Elena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_umfpoiibn4ht4a86g4iqj8o7v5